Viewing Study NCT01883505


Ignite Creation Date: 2025-12-25 @ 3:30 AM
Ignite Modification Date: 2026-03-26 @ 8:23 AM
Study NCT ID: NCT01883505
Status: COMPLETED
Last Update Posted: 2024-01-18
First Post: 2013-06-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 2a Study Followed to Evaluate the Safety, Tolerability and Levodopa Pharmacokinetics in Levodopa-treated Parkinson's Disease Patients Receiving ND0612
Sponsor: NeuroDerm Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module